Day: December 16, 2022

Figure 1 Olaroz and Cauchari showing Maria Victoria tenementBRISBANE, Australia, Dec. 15, 2022 (GLOBE NEWSWIRE) — Allkem Limited (ASX|TSX: “Allkem,” the Company”) has completed the sale of Borax Argentina S.A (“Borax”) to Golden Wattle Springs Pty Ltd (“Golden Wattle”) and has acquired the María Victoria lithium tenement from Minera Santa Rita S.R.L (“MSR”) (the “Transactions”). Under the Transactions:Allkem transferred to Golden Wattle (a group associated with MSR) all of the issued shares in the two Borax holding companies and US$14 million cash for employee and rehabilitation liabilities; and MSR has sold to an Allkem subsidiary 100% ownership of the Maria Victoria Tenement, as described in more detail below. The transfer deed recording this sale is in the process of being registered by the Jujuy mining court.Existing...

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA) is pleased to announce that it has closed its previously announced non-brokered private placement financing of units (the ”Units”) for gross proceed of $500,000 (the “Offering”). The Company issued an aggregate of 5,000,000 Units at a price of $0.10 per Unit pursuant to the Offering. Each Unit consists of one common share in the capital of the Company (each, a “Common Share“) and one Common Share purchase warrant (each whole warrant, a “Warrant“). Each Warrant entitles the holder to purchase one Common Share at an exercise price of $0.15 until December 15th, 2025. Terra’s CEO, Alex Miskovic, commented:...

– Ticker symbol to change from BTN to FGH on NYSE American – Charlotte, NC, Dec. 15, 2022 (GLOBE NEWSWIRE) — Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company” or “Ballantyne Strong”) today announced that the Company plans to change its name to FG Group Holdings Inc., effective after trading on Friday, December 23, 2022. In conjunction with the name change, the Company’s common stock is expected to begin trading on the NYSE American exchange under the new ticker symbol “FGH” at the opening of trading on Tuesday, December 27, 2022. The name change was previously approved by the Company’s stockholders at the 2021 Annual Meeting of Stockholders. Kyle Cerminara, Chairman of Ballantyne Strong and CEO of Fundamental Global®, commented, “We have made tremendous progress evolving our business model, and the new name...

BEIJING, Dec. 15, 2022 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced the proposed dual primary listing of its Class A ordinary shares, par value US$0.0001 per share (the “Shares”) by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited (the “HKEX”). The Company’s American depositary shares (the “ADSs”), each representing two Shares, will continue to be primarily listed and traded on the Nasdaq Global Select Market (the “Nasdaq”). The Company has received a letter of in-principle approval to the listing application from the HKEX on December 15, 2022 (Beijing/Hong Kong Time) for the dual primary listing of the Shares on the Main Board of the HKEX. The listing document relating to the proposed dual primary...

New agreement leverages Sosei Heptares’ GPCR-focused structure-based drug design capabilities and Lilly’s extensive development, commercialization and therapeutic area expertise Sosei Heptares eligible to receive US$37 million upfront in cash and further development and commercial milestone payments totalling up to US$694 million plus tiered royaltiesTOKYO and CAMBRIDGE, United Kingdom, Dec. 16, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”; TSE: 4565) announces it has entered a drug discovery collaboration with Eli Lilly and Company (“Lilly”), a global biopharmaceutical company, to discover, develop and commercialize small molecules that modulate novel G protein-coupled receptor (GPCR) targets associated with diabetes and metabolic diseases. This new agreement will leverage Sosei Heptares’ StaR® technology...